Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,822,111
-
Total 13F shares
-
55,061,050
-
Share change
-
+54,507,177
-
Total reported value
-
$432,778,373
-
Put/Call ratio
-
95%
-
Price per share
-
$7.86
-
Number of holders
-
88
-
Value change
-
+$428,425,541
-
Number of buys
-
83
Institutional Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q4 2022
As of 31 Dec 2022,
Zymeworks Inc. - Common Stock (ZYME) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,061,050 shares.
The largest 10 holders included
EcoR1 Capital, LLC, Redmile Group, LLC, BVF INC/IL, MORGAN STANLEY, PERCEPTIVE ADVISORS LLC, Rubric Capital Management LP, VANGUARD GROUP INC, CREDIT SUISSE AG/, BNP PARIBAS ASSET MANAGEMENT Holding S.A., and BAKER BROS. ADVISORS LP.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.